|
|
Article: FDA approves first 1-day, oral antiviral treatment of cold sores.
- Article from:
- Biotech Week
- Article date:
- November 6, 2002
CopyrightCOPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2002 NOV 6 - (NewsRx.com & NewsRx.net) -- GlaxoSmithKline announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for Valtrex (valacyclovir HCl) caplets for the treatment of cold sores in healthy adults, making Valtrex the first 1-day, oral antiviral medication proven to shorten the duration of a cold sore outbreak.
Cold sores, also known as herpes labialis or fever blisters, are highly infectious sores on the lip and outer edge of the mouth.
"This approval means that cold sore sufferers now have a 1-day, oral medication available which shortens the duration of the disease by blocking growth of ...